Tues., Sept. 20, 2016 | 10:00-11:15 a.m. CT | Live MBHB Webinar via WebEx
The invalidity proceedings before the Patent Trial and Appeal Board (PTAB) created by the America Invents Act had an almost immediate impact on litigation defense strategies in the financial services and technology fields. The impact in the bio/pharma field was slower, but has steadily increased. Even the highly regulated areas of ANDA and biosimilar patent litigation are being impacted by the more routine use of these PTAB invalidity proceedings.
Join us as we discuss the following topics:
Presenter(s): MBHB partners Alison Baldwin and Paula Fritsch, Ph.D.
NOTE: MCLE credit is not available for this archived recording.